6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79727R0039

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued a solicitation (Procurement Identifier: 36E79727R0039) for the supply of Latanoprost Ophthalmic Solution. This procurement is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating a focus on pharmaceutical products. The primary objective of this solicitation is to secure a reliable source for Latanoprost Ophthalmic Solution, a medication commonly used in the treatment of glaucoma and ocular hypertension. The intended outcome is to ensure the consistent availability of this essential pharmaceutical product for veterans receiving care through the VA healthcare system. Contractors are expected to provide Latanoprost Ophthalmic Solution that meets all applicable regulatory standards and quality requirements, supporting the VA’s mission to deliver high-quality healthcare to veterans. Key requirements for this procurement include the manufacturing and timely delivery of Latanoprost Ophthalmic Solution in accordance with the specifications outlined in the solicitation documents. Offerors must demonstrate their capability to produce and supply pharmaceutical preparations that comply with federal regulations and VA standards. The solicitation may include additional requirements regarding packaging, labeling, and distribution logistics, as is typical for pharmaceutical supply contracts, though specific details should be reviewed in the attached solicitation documents. The contracting entity for this opportunity is the NAC Pharmaceuticals office, a federal office within the Department of Veterans Affairs. The primary point of contact for this solicitation is James P. Sullivan, who can be reached via email at [email protected] for any questions or clarifications regarding the procurement process. This opportunity is currently active, with a posting date of October 30, 2026, and a response deadline of November 17, 2026. Interested contractors are encouraged to review the full solicitation and its attachments, which are available through the official SAM.gov listing (Opportunity ID: fa06cc4e0c4244c5af530a232cfe665f). The notice does not specify any set-aside requirements or special considerations; therefore, all qualified manufacturers and suppliers of pharmaceutical preparations are invited to submit proposals. In summary, this solicitation represents a significant opportunity for pharmaceutical manufacturers specializing in ophthalmic solutions to partner with the Department of Veterans Affairs in supporting the health and well-being of veterans nationwide. Contractors should ensure they meet all regulatory and quality standards and are prepared to fulfill the VA’s requirements for Latanoprost Ophthalmic Solution throughout the contract lifecycle.